Dose-Response Relationships
Dose-response relationships describe how drug effects change with increasing concentration. Understanding these curves is fundamental to pharmacology and toxicology.
## Overview
The dose-response relationship is the cornerstone of pharmacology. It describes the magnitude of effect produced by different drug concentrations. Every therapeutic and toxic effect follows dose-response principles, making this concept essential for rational drug dosing and toxicity prediction.
## Graded Dose-Response Curves
A graded dose-response curve plots drug concentration (x-axis, logarithmic) against response magnitude (y-axis) in a single biological system. The resulting sigmoidal curve reveals key parameters:
- **EC50 (or ED50)**: The concentration (or dose) producing 50% of maximal effect. It measures potency — lower EC50 means higher potency.
- **Emax**: The maximum achievable effect. It measures efficacy.
- **Hill coefficient**: Describes the steepness of the curve. Higher values indicate greater cooperativity and a narrower concentration range between no effect and full effect.
Two drugs may differ in potency (different EC50) while having equal efficacy (same Emax), or vice versa. Clinically, efficacy often matters more than potency because potency can be compensated by adjusting the dose.
## Quantal Dose-Response Curves
Quantal responses are all-or-none outcomes (e.g., seizure or no seizure, alive or dead) plotted across a population. The quantal curve shows the cumulative percentage of individuals responding at each dose level. From this curve, three critical values are derived:
- **ED50**: Dose effective in 50% of the population
- **TD50**: Dose toxic in 50% of the population
- **LD50**: Dose lethal in 50% of the population
The **therapeutic index** (TI = TD50/ED50 or LD50/ED50) is derived from quantal dose-response data.
## Potency vs. Efficacy
Potency compares the doses required for equivalent effects (horizontal shift in the curve). Morphine is more potent than codeine because lower doses achieve the same analgesic effect. Efficacy compares maximum achievable effects (vertical difference). A full agonist has higher efficacy than a partial agonist regardless of dose.
## Toxicological Implications
**Threshold dose** is the minimum dose causing a detectable toxic effect. Below this, the body's homeostatic and repair mechanisms prevent injury. For carcinogens, regulatory agencies often assume no threshold exists (linear no-threshold model), while non-carcinogenic toxicants typically have identifiable thresholds.
**Hormesis** describes a biphasic response where low doses stimulate and high doses inhibit. Some toxicants show beneficial effects at very low concentrations.
## Key Takeaways
- EC50 measures potency; Emax measures efficacy
- Graded curves show individual response; quantal curves show population response
- Therapeutic index is derived from quantal ED50 and TD50
- Efficacy is generally more clinically important than potency
- Toxicological thresholds define the boundary between safe and harmful exposure